Coronavirus pill

Pfizer’s new drug, Paxlovid, is a combination oral treatment for people with mild to moderate symptoms who are at high risk of developing severe COVID-19. (Reuters/Illustration)

First generic version of new Pfizer COVID-19 pill enters Bangladeshi pharmacies

  • In trials, Paxlovid reduced the risk of COVID-19-related hospitalization and death by 89 percent
  • Pfizer’s treatment is protected by patents, but least-developed countries such as Bangladesh are not bound by them
By SHEHAB SUMON ·